Gingival fibromatosis-progressive deafness syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2027OMIM:135550H90.3
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Gingival fibromatosis-progressive deafness syndrome, also known as Jones syndrome or gingival fibromatosis with sensorineural hearing loss, is a rare genetic disorder characterized by the combination of gingival fibromatosis (progressive overgrowth of the gum tissue) and sensorineural hearing loss that worsens over time. The gingival overgrowth typically becomes apparent during childhood, often around the time of eruption of the permanent teeth, and can be severe enough to cover the teeth partially or completely, interfering with dental alignment, chewing, and oral hygiene. The sensorineural hearing loss affects the inner ear or auditory nerve pathways and tends to be progressive, potentially leading to significant hearing impairment. The condition primarily affects two body systems: the oral cavity (gingival tissues) and the auditory system. The gingival fibromatosis is characterized by firm, non-tender, pink enlargement of the gums that may recur even after surgical reduction (gingivectomy). The hearing loss is bilateral and sensorineural in nature, distinguishing it from conductive hearing loss. There is no known cure for this syndrome. Management is symptomatic and includes periodic surgical removal of excess gingival tissue (gingivectomy) to maintain oral function and hygiene, along with hearing aids or other auditory rehabilitation strategies to address the progressive hearing loss. Regular dental and audiological follow-up is essential for optimal management. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Gingival fibromatosisHP:0000169
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Gingival fibromatosis-progressive deafness syndrome.

View clinical trials →

No actively recruiting trials found for Gingival fibromatosis-progressive deafness syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Gingival fibromatosis-progressive deafness syndrome community →

Specialists

1 foundView all specialists →
DS
Dr Faaiz Ali Shah
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Gingival fibromatosis-progressive deafness syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Gingival fibromatosis-progressive deafness syndromeForum →

No community posts yet. Be the first to share your experience with Gingival fibromatosis-progressive deafness syndrome.

Start the conversation →

Latest news about Gingival fibromatosis-progressive deafness syndrome

No recent news articles for Gingival fibromatosis-progressive deafness syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Gingival fibromatosis-progressive deafness syndrome

What is Gingival fibromatosis-progressive deafness syndrome?

Gingival fibromatosis-progressive deafness syndrome, also known as Jones syndrome or gingival fibromatosis with sensorineural hearing loss, is a rare genetic disorder characterized by the combination of gingival fibromatosis (progressive overgrowth of the gum tissue) and sensorineural hearing loss that worsens over time. The gingival overgrowth typically becomes apparent during childhood, often around the time of eruption of the permanent teeth, and can be severe enough to cover the teeth partially or completely, interfering with dental alignment, chewing, and oral hygiene. The sensorineural h

How is Gingival fibromatosis-progressive deafness syndrome inherited?

Gingival fibromatosis-progressive deafness syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Gingival fibromatosis-progressive deafness syndrome typically begin?

Typical onset of Gingival fibromatosis-progressive deafness syndrome is childhood. Age of onset can vary across affected individuals.

Which specialists treat Gingival fibromatosis-progressive deafness syndrome?

1 specialists and care centers treating Gingival fibromatosis-progressive deafness syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.